Detalhe da pesquisa
1.
An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.
Blood
; 2024 Mar 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38493482
2.
Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions.
J Oncol Pharm Pract
; 30(2): 342-353, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37113049
3.
Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia.
J Oncol Pharm Pract
; 29(6): 1326-1333, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35946111
4.
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.
Am J Hematol
; 95(9): 1006-1014, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32390196
5.
Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease.
Transpl Infect Dis
; 22(1): e13222, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31782875
6.
Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions.
J Oncol Pharm Pract
; 26(4): 835-845, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31575355
7.
American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States.
Biol Blood Marrow Transplant
; 25(1): 26-33, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30266675
8.
Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.
Biol Blood Marrow Transplant
; 24(10): 2081-2087, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29753159
9.
Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.
Biol Blood Marrow Transplant
; 24(7): 1406-1414, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29678639
10.
Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study.
Ann Hematol
; 99(5): 1137-1139, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-32140894
11.
Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation.
Clin Hematol Int
; 6(2): 1-10, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38817311
12.
Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations.
Clin Hematol Int
; 6(2): 11-20, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38817307
13.
Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Transplant Cell Ther
; 30(2): 131-142, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37951502
14.
Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia.
Bone Marrow Transplant
; 2024 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38879608
15.
Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation.
Clin Hematol Int
; 4(3): 89-98, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-36131129
16.
Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA).
Explor Res Clin Soc Pharm
; 7: 100163, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35957656
17.
Chimeric antigen receptor T-cell therapy: Challenges and framework of outpatient administration.
EJHaem
; 3(Suppl 1): 54-60, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35844300
18.
Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma.
JCO Oncol Pract
; 18(9): e1475-e1483, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35700416
19.
Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic.
Antimicrob Steward Healthc Epidemiol
; 2(1): e11, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36310802
20.
Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation.
Transplant Cell Ther
; 28(5): 277.e1-277.e6, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35181561